Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells

International Journal of COPD

Volumn 3, Issue 3, 2008, Pages 469-475

  van der Deen, Margaretha ^a   Homan, Sandra ^a   Timmer Bosscha, Hetty ^a   Scheper, Rik J ^b   Timens, Wim ^a   Postma, Dirkje S ^a   de Vries, Elisabeth G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bronchus epithelium; COPD; Drugs; MRP1; Multidrug resistance; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; BUDESONIDE; CARBOXYFLUORESCEIN; FORMOTEROL; IPRATROPIUM BROMIDE; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG TERM CARE; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ACETYLCYSTEINE; BIOLOGICAL TRANSPORT; BRONCHI; BRONCHODILATOR AGENTS; BUDESONIDE; CHOLINERGIC ANTAGONISTS; DRUG RESISTANCE, MULTIPLE; EPITHELIAL CELLS; ETHANOLAMINES; EXPECTORANTS; FLOW CYTOMETRY; HUMANS; IPRATROPIUM; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 54949123797     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Akan I, Akan S, Akca H, et al. 2005. Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and buthionine sulfoximine. Cancer Cell Int, 5:22.
2. Alsaeedi A, Sin DD, McAlister FA. 2002. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med, 113:59-65.
3. Anderson GP, Linden A, Rabe KF. 1994. Why are long-acting beta-adrenoceptor agonists long-acting? Eur Respir J, 7:569-78.
4. Anthonisen NR, Connett JE, Kiley JP, et al. 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA, 272:1497-505.
5. Bagrij T, Klokouzas A, Hladky SB, et al. 2001. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1. Biochem Pharmacol, 62:199-206.
6. Bandi N, Kompella UB. 2002. Budesonide reduces multidrug resistance-associated protein 1 expression in an airway epithelial cell line (Calu-1). Eur J Pharmacol, 437:9-17.
7. Borchard G, Cassara ML, Roemele PE, et al. 2002. Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3). J Pharm Sci, 91:1561-7.
8. Brechot JM, Hurbain I, Fajac A, et al. 1998. Different pattern of MRP localization in ciliated and basal cells from human bronchial epithelium. J Histochem Cytochem, 46:513-7.
9. Calverley PM, Boonsawat W, Cseke Z, et al. 2003. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J, 22:912-9.
10. Cole SP, Bhardwaj G, Gerlach JH, et al. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258:1650-4.
11. Cozens AL, Yezzi MJ, Kunzelmann K, et al. 1994. CFTR expression chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol, 10:38-47.
12. Decramer M, Rutten-van Molken M, Dekhuijzen PN, et al. 2005. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet, 365:1552-60.
13. Dekkers DW, Comfurius P, van Gool RG, et al. 2000. Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes. Biochem J, 350:531-5.
14. Evers R, de Haas M, Sparidans R, et al. 2000. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer, 83:375-83.
15. Gillissen A, Jaworska M, Orth M, et al. 1997. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir Med, 91:159-68.
16. Gustafsson B, Persson CG. 1991. Effect of different bronchodilators on airway smooth muscle responsiveness to contractile agents. Thorax, 46:360-5.
17. Hamilton KO, Yazdanian MA, Audus KL. 2002. Contribution of efflux pump activity to the delivery of pulmonary therapeutics. Curr Drug Metab, 3:1-12.
18. Johnson M, Rennard S. 2001. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest, 120:258-70.
19. Langmann T, Mauerer R, Zahn A, et al. 2003. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem, 49:230-8.
20. Leslie EM, Deeley RG, Cole SP. 2001. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology, 167:3-23.
21. Leslie EM, Ito K, Upadhyaya P, et al. 2001. Transport of the beta-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem, 276:27846-54.
22. Nagy AM, Vanderbist F, Parij N, et al. 1997. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulm Pharmacol Ther, 10:287-92.
23. O'Connell EJ. 2003. Review of the unique properties of budesonide. Clin Ther, 25(Suppl C):C42-C60.
24. Scheffer GL, Pijnenborg AC, Smit EF, et al. 2002. Multidrug resistance related molecules in human and murine lung. J Clin Pathol, 55:332-9.
25. Stey C, Steurer J, Bachmann S, et al. 2000. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J, 16:253-62.
26. Sutherland ER, Allmers H, Ayas NT, et al. 2003. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax, 58:937-41.
27. van der Deen M, de Vries EG, Timens W, et al. 2005. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res, 6:59.
28. van der Deen M, Marks H, Willemse BW, et al. 2006. Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients. Virchows Arch, 449:682-8.
29. van der Kolk DM, de Vries EG, Koning JA, et al. 1998. Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. Clin Cancer Res, 4:1727-36.
30. Wielinga PR, van der Heijden I, Reid G, et al. 2003. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem, 278:17664-71.